{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T21:59:19Z","timestamp":1782338359041,"version":"3.54.5"},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.transproceed.2022.01.020","type":"journal-article","created":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T16:24:34Z","timestamp":1646929474000},"page":"1137-1140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Chronic Kidney Disease in Patients After Allogeneic Hematopoietic Cell Transplant"],"prefix":"10.1016","volume":"54","author":[{"given":"Malgorzata","family":"K\u0119pska-Dzili\u0144ska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga","family":"Chomicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Karakulska-Prystupiuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Tomaszewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz W\u0142adys\u0142aw","family":"Basak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8701-8171","authenticated-orcid":false,"given":"Jolanta","family":"Malyszko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2022.01.020_bib0001","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2215\/CJN.08580719","article-title":"Acute kidney injury and CKD associated with hematopoietic stem cell transplantation","volume":"15","author":"Renaghan","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2022.01.020_bib0002","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/sj.bmt.1705643","article-title":"Significant increase in end-stage renal disease after hematopoietic stem cell transplantation","volume":"39","author":"Cohen","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transproceed.2022.01.020_bib0003","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.krcp.2013.07.004","article-title":"De novo glomerulitis associated with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: a single-center experience","volume":"32","author":"Cho","year":"2013","journal-title":"Kidney Res Clin Pract"},{"key":"10.1016\/j.transproceed.2022.01.020_bib0004","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1053\/j.ackd.2013.08.007","article-title":"The kidney effects of hematopoietic stem cell transplantation","volume":"21","author":"Sawinski","year":"2014","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.transproceed.2022.01.020_bib0005","first-page":"1","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","year":"2013","journal-title":"Kidney Inter Suppl"},{"key":"10.1016\/j.transproceed.2022.01.020_bib0006","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/ndt\/gfh720","article-title":"Comparison of renal injury in myeloablative autologous, myeloablative allogeneic and non-myeloablative allogeneic haematopoietic cell transplantation","volume":"20","author":"Schrier","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2022.01.020_bib0007","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood.V91.3.756","article-title":"Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases","volume":"91","author":"Slavin","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.transproceed.2022.01.020_bib0008","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.bbmt.2009.05.006","article-title":"Moderate renal function impairment does not affect outcomes of reduced-intensity conditioning with fludarabine and melphalan for allogeneic hematopoietic stem cell transplantation","volume":"15","author":"de Souza","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.transproceed.2022.01.020_bib0009","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.bbmt.2008.08.015","article-title":"Successful outcome after nonmyeloablative allogeneic hematopoietic stem cell transplantation in patients with renal dysfunction","volume":"14","author":"Kersting","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.transproceed.2022.01.020_bib0010","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1681\/ASN.2006020118","article-title":"Chronic kidney disease in long-term survivors of hematopoietic cell transplantation: epidemiology, pathogenesis, and treatment","volume":"17","author":"Hingorani","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2022.01.020_bib0011","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1111\/j.1600-6143.2008.02408.x","article-title":"Chronic kidney disease after hematopoietic cell transplantation: a systematic review","volume":"8","author":"Ellis","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2022.01.020_bib0012","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.ijrobp.2006.02.021","article-title":"Renal dysfunction after total body irradiation: dose-effect relationship","volume":"65","author":"Kal","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.transproceed.2022.01.020_bib0013","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/ndt\/gfp485","article-title":"Chronic kidney disease in long-term survivors of myeloablative allogeneic haematopoietic cell transplantation: prevalence and risk factors","volume":"25","author":"Ando","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2022.01.020_bib0014","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/bmt.2012.85","article-title":"The significant impact of acute kidney injury on CKD in patients who survived over 10 years after myeloablative allogeneic SCT","volume":"48","author":"Shimoi","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transproceed.2022.01.020_bib0015","doi-asserted-by":"crossref","first-page":"866","DOI":"10.2215\/CJN.10630917","article-title":"Changes in glomerular filtration rate and impact on long-term survival among adults after hematopoietic cell transplantation: a prospective cohort study","volume":"13","author":"Hingorani","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2022.01.020_bib0016","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.ekir.2017.12.013","article-title":"Renal thrombotic microangiopathy after hematopoietic stem cell transplantation: involvement of chronic graft-versus-host disease","volume":"3","author":"Mii","year":"2018","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.transproceed.2022.01.020_bib0017","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.bbmt.2011.11.029","article-title":"Important drug interactions in hematopoietic stem cell transplantation: what every physician should know","volume":"18","author":"Glotzbecker","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.transproceed.2022.01.020_bib0018","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.bbmt.2008.09.015","article-title":"Albuminuria in hematopoietic cell transplantation patients: prevalence, clinical associations, and impact on survival","volume":"14","author":"Hingorani","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.transproceed.2022.01.020_bib0019","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000450798","article-title":"Emergence of dipstick proteinuria predicts overt nephropathy in patients following stem cell transplantation","volume":"135","author":"Momoki","year":"2017","journal-title":"Nephron"},{"key":"10.1016\/j.transproceed.2022.01.020_bib0020","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1038\/bmt.2012.271","article-title":"New-onset microalbuminuria following allogeneic myeloablative SCT is a sign of near-term decrease in renal function","volume":"48","author":"Morito","year":"2013","journal-title":"Bone Marrow Transplant"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134522001221?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134522001221?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:43:34Z","timestamp":1758577414000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134522001221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0041134522001221"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2022.01.020","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic Kidney Disease in Patients After Allogeneic Hematopoietic Cell Transplant","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2022.01.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}